The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week...
Saved in:
Published in | Gut microbes Vol. 13; no. 1; pp. 1 - 11 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.01.2021
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10
−3
) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. |
---|---|
AbstractList | Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10-3) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = -0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = -0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp . and Bacteroides spp , and significant decreases in the fatty-liver associated Collinsella spp . On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate ( p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate ( p < .002) and nearly significant increases in butyrate ( p < .053). Coprococcus , which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10 −3 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. Prebiotics are compounds in food that benefit health affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in . and , and significant decreases in the fatty-liver associated . On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate ( < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate ( < .002) and nearly significant increases in butyrate ( < .053). , which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), = 1.4 x 10 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = -0.381 (0.01), = .001) and VLDL-TG (Beta (SE) = -0.372 (0.04), = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10−3) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10 −3 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient. |
Author | Vijay, Amrita Spector, Tim D Astbury, Stuart Le Roy, Caroline Valdes, Ana M |
Author_xml | – sequence: 1 givenname: Amrita orcidid: 0000-0002-9595-5680 surname: Vijay fullname: Vijay, Amrita email: amrita.vijay@nottingham.ac.uk organization: School of Medicine, University of Nottingham – sequence: 2 givenname: Stuart orcidid: 0000-0002-1919-3952 surname: Astbury fullname: Astbury, Stuart organization: Nottingham University Hospitals NHS Trust and the University of Nottingham – sequence: 3 givenname: Caroline surname: Le Roy fullname: Le Roy, Caroline organization: King's College London – sequence: 4 givenname: Tim D surname: Spector fullname: Spector, Tim D organization: King's College London – sequence: 5 givenname: Ana M orcidid: 0000-0003-1141-4471 surname: Valdes fullname: Valdes, Ana M organization: Nottingham University Hospitals NHS Trust and the University of Nottingham |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33382352$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtv1DAUhSNUREvpTwB5ySbFb8csEFXFo1IlNmVtOc711CWJB9vTdv49DjMd0Q3e2Do-97u-Pq-boznO0DRvCT4nuMMfiOYaayXPKaZV6iQjjL1oTha9xbrjR4ezksfNWc53uC7OFZbsVXPMGOsoE_SkgZtbQOsEfYglOATegysZRY_iBCvbMuRtKVtkXRhQ3qzXI0wwF1tCnD-iC5TDY_sA8AslOw9xChkGFOYC6b66qgeVFOz4pnnp7ZjhbL-fNj-_frm5_N5e__h2dXlx3TrBeGlZp2mPpaaaik7YHhOh_SA55YoLqQU46oQblFJeKE6s7J1noMBbpYWgjJ02VzvuEO2dWacw2bQ10QbzV4hpZWyqc45gPJGc2x64rXBMnfYcNBDKe1Lb9LyyPu1Y600_weDqPMmOz6DPb-Zwa1bx3ijVEUkXwPs9IMXfG8jF1O9xMI52hrjJZpmKS9FJXK1iZ3Up5pzAH9oQbJbEzVPiZknc7BOvde_-feOh6infavi8M4TZxzTZh5jGwRS7HWPyNTIXsmH_7_EHQTS9AQ |
CitedBy_id | crossref_primary_10_1016_j_redox_2023_102730 crossref_primary_10_1097_ICL_0000000000000905 crossref_primary_10_3390_nu15122675 crossref_primary_10_3390_metabo14060311 crossref_primary_10_1080_19490976_2021_1897212 crossref_primary_10_1016_j_ncl_2023_07_005 crossref_primary_10_1038_s41467_024_45332_w crossref_primary_10_3389_fpsyt_2023_1193490 crossref_primary_10_1007_s00394_021_02785_9 crossref_primary_10_3390_jcm10132903 crossref_primary_10_3389_fnut_2023_1205377 crossref_primary_10_1097_MCO_0000000000000865 crossref_primary_10_1080_10408398_2022_2142194 crossref_primary_10_1093_jn_nxab113 crossref_primary_10_1128_spectrum_02416_22 crossref_primary_10_3390_nu14224776 crossref_primary_10_1080_19490976_2022_2126274 crossref_primary_10_3390_nu14153099 crossref_primary_10_3389_fnut_2022_847114 crossref_primary_10_1155_2024_8925691 crossref_primary_10_1016_j_jconrel_2024_03_039 crossref_primary_10_3389_fnut_2022_854725 crossref_primary_10_1016_j_csbj_2023_10_035 crossref_primary_10_1016_j_tips_2022_02_001 crossref_primary_10_3390_nu16071054 crossref_primary_10_1016_j_phymed_2023_155068 crossref_primary_10_1038_s41522_022_00287_y crossref_primary_10_59118_HUGX5553 crossref_primary_10_3390_nu16050694 crossref_primary_10_1016_j_ijsu_2022_106751 crossref_primary_10_3390_nu14010145 crossref_primary_10_1016_j_chom_2022_04_016 crossref_primary_10_3390_microorganisms10091727 crossref_primary_10_2147_DDDT_S404479 crossref_primary_10_3389_fnut_2024_1327863 crossref_primary_10_3390_nu14030614 crossref_primary_10_1080_19390211_2023_2198007 crossref_primary_10_3389_fmolb_2023_1182643 crossref_primary_10_1093_ajcn_nqac151 crossref_primary_10_3390_nu14142970 crossref_primary_10_1017_gmb_2023_14 crossref_primary_10_1080_19490976_2021_1997559 crossref_primary_10_1007_s00284_023_03223_1 crossref_primary_10_3390_nu14173545 crossref_primary_10_3389_fcvm_2021_691564 crossref_primary_10_3390_foods11020146 crossref_primary_10_3390_metabo11080531 crossref_primary_10_3389_fpsyt_2022_904426 crossref_primary_10_1080_09546634_2023_2299107 crossref_primary_10_2147_IDR_S390582 crossref_primary_10_3390_nu15224802 crossref_primary_10_1038_s41598_024_57627_5 crossref_primary_10_1080_19490976_2022_2120344 crossref_primary_10_3390_nu14122504 crossref_primary_10_3390_ijms25010438 crossref_primary_10_1016_j_jnutbio_2023_109326 crossref_primary_10_3390_fermentation9020126 crossref_primary_10_1017_S0007114521003251 crossref_primary_10_1097_YCO_0000000000000758 crossref_primary_10_1097_TP_0000000000004629 crossref_primary_10_1016_j_tifs_2023_104141 crossref_primary_10_1016_j_xcrm_2023_100993 crossref_primary_10_1016_j_ijbiomac_2022_03_063 |
Cites_doi | 10.1136/gutjnl-2017-314968 10.1128/AEM.68.10.5186-5190.2002 10.1186/s12944-019-1167-4 10.3390/biom9040121 10.1038/s41598-019-48775-0 10.1016/S0140-6736(18)31809-9 10.1186/s40168-020-00887-w 10.1038/nrgastro.2017.75 10.1155/2014/348959 10.1186/1476-511X-13-140 10.1038/nature12820 10.1080/07315724.2002.10719248 10.3109/08830180903197480 10.1161/CIRCGENETICS.114.000216 10.1038/nature11319 10.1161/HYPERTENSIONAHA.107.090720 10.1038/nrmicro3344 10.1126/scitranslmed.3004244 10.1056/NEJMoa1804989 10.1093/advances/nmz074 10.1007/s11883-004-0087-5 10.3390/nu11061381 10.1111/apt.13746 10.3390/ijms21041249 10.1038/ismej.2017.196 10.1079/PNS2002207 10.1017/S0007114512001560 10.1016/j.chom.2018.05.012 10.1038/s41598-017-10382-2 10.1161/CIRCRESAHA.118.314642 10.1007/s10096-018-3220-z 10.1186/s12944-016-0245-0 10.1126/science.1223813 10.1136/heart.89.12.1445 10.1136/gutjnl-2015-310861 10.1096/fj.201802445R 10.1080/19490976.2017.1299309 10.1111/j.1365-277X.2005.00593.x 10.1001/2012.jama.11374 10.1038/s41598-017-16189-5 10.1371/journal.pone.0238006 10.1016/j.cell.2016.05.041 10.1038/s41598-019-52678-5 10.1016/j.chom.2016.04.017 10.1038/s41467-019-12476-z 10.1056/NEJMoa1811403 10.1128/microbiolspec.BAD-0019-2017 10.1080/17512433.2017.1333902 10.1016/j.cell.2014.09.053 10.1056/NEJMoa1812792 |
ContentType | Journal Article |
Copyright | 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 The Author(s) |
Copyright_xml | – notice: 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 – notice: 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 The Author(s) |
DBID | 0YH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1080/19490976.2020.1863133 |
DatabaseName | Taylor & Francis Open Access Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access Journals url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | A. VIJAY ET AL |
EISSN | 1949-0984 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_f1644abe4a47402c9f4e9e124b1ec2b4 10_1080_19490976_2020_1863133 33382352 1863133 |
Genre | Research Paper Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/N01183X/1 |
GroupedDBID | --- 00X 0R~ 0YH 30N 4.4 53G AAAVI AAJNR ABBKH ABJVF ABPEM ABQHQ ACGFS ACTIO ADBBV ADCVX AEGYZ AEISY AFOLD AHDLD AIJEM AIRXU ALMA_UNASSIGNED_HOLDINGS AOIJS AQRUH BABNJ BAWUL BLEHA CCCUG DGEBU DIK DKSSO EBS EMOBN F5P FUNRP FVPDL GROUPED_DOAJ HYE KYCEM LJTGL M4Z MM. O9- OK1 RPM SNACF SV3 TFL TFT TFW TR2 TTHFI V1K ZGOLN ABCCY AGYJP C1A CGR CUY CVF ECM EIF EJD H13 IPNFZ NPM OVD RIG TDBHL TEORI AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c534t-3892b069292585ab0159fd6424745695ec2c5cd777f5741a6bcf3e7efa7955233 |
IEDL.DBID | RPM |
ISSN | 1949-0976 |
IngestDate | Tue Oct 22 15:02:07 EDT 2024 Tue Sep 17 21:26:17 EDT 2024 Fri Aug 16 22:34:05 EDT 2024 Fri Aug 23 00:42:24 EDT 2024 Sat Sep 28 08:34:02 EDT 2024 Fri Jun 09 04:11:43 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Gut microbiota Omega 3 Fibre Dietary intervention Prebiotic |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c534t-3892b069292585ab0159fd6424745695ec2c5cd777f5741a6bcf3e7efa7955233 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-1919-3952 0000-0002-9595-5680 0000-0003-1141-4471 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781624/ |
PMID | 33382352 |
PQID | 2474465860 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f1644abe4a47402c9f4e9e124b1ec2b4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7781624 crossref_primary_10_1080_19490976_2020_1863133 informaworld_taylorfrancis_310_1080_19490976_2020_1863133 proquest_miscellaneous_2474465860 pubmed_primary_33382352 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Gut microbes |
PublicationTitleAlternate | Gut Microbes |
PublicationYear | 2021 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | cit0033 cit0034 cit0031 cit0032 cit0030 Astbury S (cit0044) 2019; 07 cit0039 cit0037 cit0038 cit0035 cit0036 cit0022 cit0023 cit0020 cit0021 cit0028 cit0029 cit0026 cit0027 cit0024 cit0025 cit0011 cit0012 cit0010 Mori TA (cit0050) 2010; 56 cit0051 cit0052 cit0019 cit0017 cit0018 cit0015 cit0016 cit0013 cit0014 cit0001 cit0045 cit0042 cit0043 cit0040 cit0041 cit0008 cit0009 cit0006 cit0007 cit0004 cit0048 cit0005 cit0049 cit0002 cit0046 cit0003 cit0047 |
References_xml | – ident: cit0021 doi: 10.1136/gutjnl-2017-314968 – ident: cit0037 doi: 10.1128/AEM.68.10.5186-5190.2002 – ident: cit0022 doi: 10.1186/s12944-019-1167-4 – ident: cit0047 doi: 10.3390/biom9040121 – ident: cit0048 doi: 10.1038/s41598-019-48775-0 – ident: cit0052 doi: 10.1016/S0140-6736(18)31809-9 – ident: cit0009 doi: 10.1186/s40168-020-00887-w – ident: cit0011 doi: 10.1038/nrgastro.2017.75 – ident: cit0020 doi: 10.1155/2014/348959 – ident: cit0024 doi: 10.1186/1476-511X-13-140 – ident: cit0004 doi: 10.1038/nature12820 – ident: cit0040 doi: 10.1080/07315724.2002.10719248 – ident: cit0015 doi: 10.3109/08830180903197480 – volume: 07 start-page: 1 year: 2019 ident: cit0044 publication-title: Gut Microbes contributor: fullname: Astbury S – ident: cit0033 doi: 10.1161/CIRCGENETICS.114.000216 – ident: cit0005 doi: 10.1038/nature11319 – ident: cit0049 doi: 10.1161/HYPERTENSIONAHA.107.090720 – ident: cit0038 doi: 10.1038/nrmicro3344 – ident: cit0002 doi: 10.1126/scitranslmed.3004244 – ident: cit0041 doi: 10.1056/NEJMoa1804989 – ident: cit0012 doi: 10.1093/advances/nmz074 – ident: cit0016 doi: 10.1007/s11883-004-0087-5 – ident: cit0051 doi: 10.3390/nu11061381 – ident: cit0026 doi: 10.1111/apt.13746 – ident: cit0034 doi: 10.3390/ijms21041249 – ident: cit0035 doi: 10.1038/ismej.2017.196 – ident: cit0036 doi: 10.1079/PNS2002207 – ident: cit0014 doi: 10.1017/S0007114512001560 – ident: cit0007 doi: 10.1016/j.chom.2018.05.012 – ident: cit0018 doi: 10.1038/s41598-017-10382-2 – ident: cit0032 doi: 10.1161/CIRCRESAHA.118.314642 – ident: cit0031 doi: 10.1007/s10096-018-3220-z – ident: cit0019 doi: 10.1186/s12944-016-0245-0 – ident: cit0001 doi: 10.1126/science.1223813 – ident: cit0027 doi: 10.1136/heart.89.12.1445 – ident: cit0030 doi: 10.1136/gutjnl-2015-310861 – ident: cit0043 doi: 10.1096/fj.201802445R – ident: cit0003 doi: 10.1080/19490976.2017.1299309 – ident: cit0025 doi: 10.1111/j.1365-277X.2005.00593.x – ident: cit0039 doi: 10.1001/2012.jama.11374 – ident: cit0046 doi: 10.1038/s41598-017-16189-5 – ident: cit0006 doi: 10.1371/journal.pone.0238006 – ident: cit0008 doi: 10.1016/j.cell.2016.05.041 – ident: cit0023 doi: 10.1038/s41598-019-52678-5 – ident: cit0029 doi: 10.1016/j.chom.2016.04.017 – ident: cit0045 doi: 10.1038/s41467-019-12476-z – ident: cit0017 doi: 10.1056/NEJMoa1811403 – ident: cit0010 doi: 10.1128/microbiolspec.BAD-0019-2017 – ident: cit0013 doi: 10.1080/17512433.2017.1333902 – ident: cit0028 doi: 10.1016/j.cell.2014.09.053 – ident: cit0042 doi: 10.1056/NEJMoa1812792 – volume: 56 start-page: 83 year: 2010 ident: cit0050 publication-title: Cell Mol Biol contributor: fullname: Mori TA |
SSID | ssj0000447063 |
Score | 2.5258162 |
Snippet | Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut... Prebiotics are compounds in food that benefit health affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome... Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut... |
SourceID | doaj pubmedcentral proquest crossref pubmed informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Aged Bacteria - classification Bacteria - genetics Bacteria - isolation & purification Bacteria - metabolism Body Mass Index Dietary intervention Dietary Supplements Fatty Acids - blood Fatty Acids, Omega-3 - administration & dosage Fatty Acids, Omega-3 - pharmacology Female Fibre Gastrointestinal Microbiome - drug effects Gut microbiota Humans Inulin - administration & dosage Inulin - pharmacology Lipids - blood Male Middle Aged Omega 3 Prebiotic Prebiotics - administration & dosage Research Paper |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na94wDDalMOhl7KPb0n3gQa9pE9ux4966sVIG26mF3oztyFsYS0rflLb_vrKdt-Qtg152VRKwJTl6HluWCNlX3Fnd1qLsRCVKAZ0oW0CyojuQTFiEAOmW64-f8vRcfL9oLhatvmJOWC4PnBV3GBDPC-sAv1PIdbwOAjRgVHI1eOZyJdBKL8hU-gcLoXIbNSTpMSdIyfX1nbY6jLIoQnrIUNRKXnO-EZhS_f5H1Uv_hUEfp1IuYtPJC_J8BpX0OE_mJdmC4RV5lttM3r0mgL5AL6_A9SO-QOcUDjoGOv6FX7bkNNhpuqPW9x1dxTafOaU82uyIHtNVf1veAPyhGNe6ER0DOtovciVpav2xS85Pvp19PS3n9gqlb7iYSoQqzFUS8RFDzmAdAgMdOuQjqOhG6gbV6xvfKaVCg7jDSucDBwXBKt0gf-VvyPYwDvCOUBGCCI77wKwXtai1Q9xppeU184CUpCAHa92ay1xFw9RzcdK1MUw0hpmNUZAv0QIPL8ci2EmArmFm1zBPuUZB9NJ-Zkp7ICE3LDH8iQF8XhvboF7jKYodYLxemagegbhNVgV5m43_MEzO47FqwwqiNtxiYx6bT4b-dyrqrVRb4-rY-x8Tf092WEy9STtFH8j2dHUNHxE7Te5TWib3lhUR0Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Taylor & Francis Open Access Journals dbid: 0YH link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9UwEA-6IngRv-36QQSv1TaZNi_eVnF5CHpyQU8hSSdrkW2X1y66__1O0vbx3qJ48JomJc3MdH6_ZDLD2GslndWrEvIGCsgBG8hXSGRFN1gLsAQB0i3Xz1_q9Ql8-lYt0YTDHFYZOXSYEkWkf3U0buuGJSLuLfFuXZAbJXYnqGlVSyJaN9ktocj7k0oX39fbbZYCQE311OKoPA5b7vH87U17Hiol8r-WxvRPYPR6TOWOkzq-x-7O6JIfTepwn93A7gG7PdWbvHzIkJSCn2_QtT114HMsB-8D78_w1OaSBzuOl9z6tuFDrPc5xZZH4b3jR3xof-e_EH9ycnBNTxqCDW93giZ5qgHyiJ0cf_z6YZ3PdRZyX0kYc8IswhU1ASVB5ME6Qgg6NERMQBG80hV64SvfKKVCRQDE1s4HiQqDVboiIisfs4Ou7_Ap4xACBCd9ENZDCaV2BEBtbWUpPBI3ydibZW3N-ZROw5RzltJFGCYKw8zCyNj7KIFt55gNOzX0m1MzG5cJxPnAOiTdUsSHvQ6AGgm5uJLm7iBjeld-ZkybIWGqXGLkPybwahG2oXWNxym2w_5iMHF5gABcXWTsyST87TSljOerlciY2lOLve_Yf9K1P1J2b6VWJZnJ4X_M-Rm7I2LoTdopes4Oxs0FviDsNLqXyTquAMscDlU priority: 102 providerName: Taylor & Francis |
Title | The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial |
URI | https://www.tandfonline.com/doi/abs/10.1080/19490976.2020.1863133 https://www.ncbi.nlm.nih.gov/pubmed/33382352 https://search.proquest.com/docview/2474465860 https://pubmed.ncbi.nlm.nih.gov/PMC7781624 https://doaj.org/article/f1644abe4a47402c9f4e9e124b1ec2b4 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFL00hY2-jH0v-wga7NWJbcmWvbeurIRByx5W6J6EJF91posdEpet_35Xsl2SMhjsJQ-KYyTdE-sc-ehegA-SG10WiYgqEYtIYCWiAkmslBXmqdBEAcIp17PzfHkhvlxmlweQjWdhgmnfmnre_FzNm_pH8FauV3Yx-sQWX89OpCwSutNiAhMC6I5ED49fIWRfQY30ubcDyXw8uVPEC9_mm0gZptRU5JxE2hE85Ny_EMvSveUpZPG_l8P0b0z0vqFyZ4U6fQyPBmrJjvshPIEDbJ7Cg77Y5O0zQEIEW2_Q1C1dwAYjB2sda1d4pSPOnO66W6ZtXbGtL_bZG8t95D6yY7atf0e_EK8ZrW5VS_DAitU7jkkWCoA8h4vTz99OltFQZCGyGRddRIQlNXFOLCkl5aAN0YPSVaRKhCRuVWZoU5vZSkrpMmIfOjfWcZTotCwzUrH8BRw2bYOvgAnnhDPculRbkYikNMQ-da55klokYTKF-Ti3at3n0lDJkKJ0jIvycVFDXKbwyUfg7mKfCjs0tJsrNQBCORJ8QhskYEkSw7Z0Aksk2mIS6rsRUyh346e6sBPi-rIliv-jA-_HYCuaV_8uRTfY3myVnx5B7C2Pp_CyD_5dN0csTUHuwWJvHPvfENJDau8B2a__-5dv4Cj1rpuwSfQWDrvNDb4j2tSZGUzi70v65PH5LGw9zMIf5w8v5xSe |
link.rule.ids | 230,315,730,783,787,867,888,2109,27514,27936,27937,53804,53806,59475,59476,60218,61007 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMGlKu_wNBJXQxJP4jW3UlEt0PbUSuVk2c64jRBJtZsK-u87zmO1W4E4cHXsaOIZZ77PHs8w9k5JZ_UsA1FBCgKwAjFDIiu6wjIHSxCgv-V6eFTOT-DraXG6dhcmhlVGDh2GRBH9vzou7rgZPYXEfSDirVPyo0TvcmqalZKY1m12p9CgopWn3-erfZYUQA0F1eIoEYdNF3n-9qYNF9Vn8r-Rx_RPaPRmUOWal9rfYdsjvOS7gz08YLewecjuDgUnrx4xJKvgFwt0dUsd-BjMwdvA2594ZoXkwXbdFbe-rvgyFvwcgsuj9j7yXb6sf4tfiD84ebiqJRPBitdrUZO8LwLymJ3sfz7em4ux0ILwhYROEGjJXVoSUsqJPVhHEEGHipgJKMJXukCf-8JXSqlQEAKxpfNBosJglS6IyconbKtpG3zGOIQAwUkfcushg0w7QqC2tDLLPRI5Sdj7aW7NxZBPw2RjmtJJGSYqw4zKSNinqIFV55gOu29oF2dmXF0mEOkD65CMSxEh9joAaiTo4jKS3UHC9Lr-TNfvhoShdImR_xDg7aRsQ_Maz1Nsg-3l0sTpAUJwZZqwp4PyV2JKGQ9YizxhasMsNr5j80lTn_fpvZWaZbROnv-HzG_Yvfnx4YE5-HL07QW7n8c4nH7b6CXb6haX-IqAVOde9yvlGn3xEck |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgEYgL74XwNBLXlCSexDW35VEtr4oDK3GzbGe8RCuSqk0Fy69nnEfVViAOe02TyJ58rr_P_jzD2AsprFHTFOISEogBS4inSGJFlVhkYIgCdKdcP8-L4xP48C0f3YSrwVYZNLTvE0V0_9VhcC9KPzriXpLuVglNo6TuMro0LQQJrcvsShF2_MMpjmS-WWZJAGRfTy08FYfHxnM8_3rTzgzVJfLfS2P6NzK676ncmqRmN5kdu9d7U84m69ZO3O-9zI8X6v8tdmOgsPyox9xtdgnrO-xqX9Ty_C5DQh5fLNFWDd3AB8MIbzxvfuCpiQX3pm3PuXFVyVehqGhvYA8IecWP-Kr6Ff9EPOM0i5YNwRBLXm05M3lXaOQeO5m9-_rmOB6KOcQuF9DGRIwymxTExjJSKMYSDVG-JPUDkjicytFlLnellNLnxHJMYZ0XKNEbqXJSy-KQHdRNjQ8YB-_BW-F8ZhykkCpLLNcURqSZQxJAEZuMH1Av-pwdOh1SoY6x0yF2eohdxF6Hz7y5OaTc7i40y1M9jGDtSViCsUgAliS6nfKACoke2ZTabiFiahskuu1WXHxfHkWL_zTg-YgoTXENezamxma90iE8QCyxSCJ2v0fYpplChE3cPIuY3MHeTj92f6mr710KcSmnKY3Fhxdo8zN27cvbmf70fv7xEbueBatPtzL1mB20yzU-Ia7W2qfdaPwDgcAwcg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+prebiotic+effects+of+omega-3+fatty+acid+supplementation%3A+A+six-week+randomised+intervention+trial&rft.jtitle=Gut+microbes&rft.au=Vijay%2C+Amrita&rft.au=Astbury%2C+Stuart&rft.au=Le+Roy%2C+Caroline&rft.au=Spector%2C+Tim+D&rft.date=2021-01-01&rft.issn=1949-0976&rft.eissn=1949-0984&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1080%2F19490976.2020.1863133&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_19490976_2020_1863133 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-0976&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-0976&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-0976&client=summon |